Please use this identifier to cite or link to this item: https://doi.org/10.1097/JTO.0b013e3181dd1386
Title: Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
Authors: Yeo, W.-L. 
Lau, M.W.
Warner, J.L.
Bodio, K.
Huberman, M.S.
Tenen, D.G. 
Kobayashi, S.
Costa, D.B.
Riely, G.J.
Kris, M.G.
Yeap, B.Y.
Pao, W.
Keywords: EGFR
Epidermal growth factor receptor
Erlotinib
Exon 19 deletions
Gefitinib
L858R
Lung cancer
Mutation
Non-small cell lung cancer
Tyrosine kinase inhibitors
Issue Date: 2010
Source: Yeo, W.-L., Lau, M.W., Warner, J.L., Bodio, K., Huberman, M.S., Tenen, D.G., Kobayashi, S., Costa, D.B., Riely, G.J., Kris, M.G., Yeap, B.Y., Pao, W. (2010). Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations. Journal of Thoracic Oncology 5 (7) : 1048-1053. ScholarBank@NUS Repository. https://doi.org/10.1097/JTO.0b013e3181dd1386
Source Title: Journal of Thoracic Oncology
URI: http://scholarbank.nus.edu.sg/handle/10635/27135
ISSN: 15560864
15561380
DOI: 10.1097/JTO.0b013e3181dd1386
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

52
checked on Dec 14, 2017

WEB OF SCIENCETM
Citations

44
checked on Nov 18, 2017

Page view(s)

208
checked on Dec 10, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.